Xtant Medical Holdings, Inc.
General ticker "XTNT" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $79.7M (TTM average)
Xtant Medical Holdings, Inc. follows the US Stock Market performance with the rate: 24.1%.
Estimated limits based on current volatility of 4.0%: low 0.48$, high 0.52$
Factors to consider:
- Total employees count: 232 (+7.9%) as of 2024
- US accounted for 90.0% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Continuing losses and financing needs, Dependence on key suppliers, Litigation risks, Market competition, Regulatory and compliance
- Current price 10.2% below estimated low
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [0.54$, 1.31$]
- 2026-12-31 to 2027-12-31 estimated range: [0.62$, 1.45$]
Financial Metrics affecting the XTNT estimates:
- Positive: with PPE of 25.4 at the end of fiscal year the price was very low
- Positive: -4.72 < Operating profit margin, % of 5.44
- Positive: 6.68 < Operating cash flow per share per price, % of 11.51
- Negative: negative Industry operating cash flow (median)
- Positive: 1.88 < Return on assets ratio (scaled to [-100,100]) of 5.02
- Positive: 42.60 < Shareholder equity ratio, % of 54.12 <= 64.25
- Positive: Inventory ratio change, % of -6.35 <= -0.75
Short-term XTNT quotes
Long-term XTNT plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $91.30MM | $117.27MM | $133.93MM |
| Operating Expenses | $101.46MM | $129.34MM | $126.64MM |
| Operating Income | $-10.16MM | $-12.07MM | $7.28MM |
| Non-Operating Income | $9.12MM | $-4.19MM | $-0.28MM |
| Interest Expense | $2.94MM | $4.16MM | $3.67MM |
| R&D Expense | $1.34MM | $2.38MM | $2.10MM |
| Income(Loss) | $-1.04MM | $-16.26MM | $7.00MM |
| Taxes | $-1.70MM | $0.19MM | $2.03MM |
| Profit(Loss)* | $0.66MM | $-16.45MM | $4.97MM |
| Stockholders Equity | $51.35MM | $42.96MM | $50.95MM |
| Inventory | $36.88MM | $38.63MM | $30.26MM |
| Assets | $92.61MM | $93.84MM | $94.14MM |
| Operating Cash Flow | $-9.52MM | $-11.90MM | $12.55MM |
| Capital expenditure | $1.46MM | $4.11MM | $2.38MM |
| Investing Cash Flow | $-24.78MM | $-3.73MM | $7.90MM |
| Financing Cash Flow | $19.69MM | $16.07MM | $-9.57MM |
| Earnings Per Share** | $0.01 | $-0.12 | $0.04 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.